vs
因美纳（ILMN）与Tempus AI, Inc.（TEM）财务数据对比。点击上方公司名可切换其他公司
因美纳的季度营收约是Tempus AI, Inc.的3.2倍（$1.2B vs $367.2M），因美纳净利率更高（28.8% vs -14.8%，领先43.6%），Tempus AI, Inc.同比增速更快（83.0% vs 5.0%），因美纳自由现金流更多（$267.0M vs $-41.5M），过去两年Tempus AI, Inc.的营收复合增速更高（58.7% vs -0.7%）
因美纳是总部位于美国加利福尼亚州圣迭戈的生物技术企业，成立于1998年4月，专注研发、生产及销售用于分析基因变异与生物功能的集成系统，产品及服务覆盖测序、基因分型、基因表达、蛋白质组学等领域，业务遍及全球超155个国家和地区。
Tempus AI是2015年由埃里克·莱夫科夫斯基在美国伊利诺伊州芝加哥创立的医疗科技企业，创立契机源于其妻子确诊乳腺癌。公司依托数据与人工智能技术，为肿瘤、心脏病、放射医学、抑郁症等领域提供包含诊断在内的精准医疗服务，2024年6月14日于纳斯达克上市，股票代码为TEM。
ILMN vs TEM — 直观对比
营收规模更大
ILMN
是对方的3.2倍
$367.2M
营收增速更快
TEM
高出78.0%
5.0%
净利率更高
ILMN
高出43.6%
-14.8%
自由现金流更多
ILMN
多$308.5M
$-41.5M
两年增速更快
TEM
近两年复合增速
-0.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $367.2M |
| 净利润 | $334.0M | $-54.2M |
| 毛利率 | 65.5% | — |
| 营业利润率 | 17.4% | -16.7% |
| 净利率 | 28.8% | -14.8% |
| 营收同比 | 5.0% | 83.0% |
| 净利润同比 | 185.5% | -316.2% |
| 每股收益（稀释后） | $2.16 | $-0.30 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ILMNTEM
| Q4 25 | $1.2B | $367.2M | ||
| Q3 25 | — | $334.2M | ||
| Q2 25 | — | $314.6M | ||
| Q1 25 | — | $255.7M | ||
| Q4 24 | $1.1B | $200.7M | ||
| Q3 24 | $1.1B | $180.9M | ||
| Q2 24 | $1.1B | $166.0M | ||
| Q1 24 | $1.1B | $145.8M |
净利润ILMNTEM
| Q4 25 | $334.0M | $-54.2M | ||
| Q3 25 | — | $-80.0M | ||
| Q2 25 | — | $-42.8M | ||
| Q1 25 | — | $-68.0M | ||
| Q4 24 | $186.0M | $-13.0M | ||
| Q3 24 | $705.0M | $-75.8M | ||
| Q2 24 | $-2.0B | $-552.2M | ||
| Q1 24 | $-126.0M | $-64.7M |
毛利率ILMNTEM
| Q4 25 | 65.5% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 65.9% | — | ||
| Q3 24 | 69.0% | — | ||
| Q2 24 | 64.8% | — | ||
| Q1 24 | 62.0% | — |
营业利润率ILMNTEM
| Q4 25 | 17.4% | -16.7% | ||
| Q3 25 | — | -18.3% | ||
| Q2 25 | — | -19.6% | ||
| Q1 25 | — | -26.9% | ||
| Q4 24 | 15.8% | -25.3% | ||
| Q3 24 | 68.6% | -29.6% | ||
| Q2 24 | -147.2% | -321.4% | ||
| Q1 24 | -10.3% | -36.5% |
净利率ILMNTEM
| Q4 25 | 28.8% | -14.8% | ||
| Q3 25 | — | -23.9% | ||
| Q2 25 | — | -13.6% | ||
| Q1 25 | — | -26.6% | ||
| Q4 24 | 16.8% | -6.5% | ||
| Q3 24 | 65.3% | -41.9% | ||
| Q2 24 | -178.8% | -332.7% | ||
| Q1 24 | -11.7% | -44.4% |
每股收益（稀释后）ILMNTEM
| Q4 25 | $2.16 | $-0.30 | ||
| Q3 25 | — | $-0.46 | ||
| Q2 25 | — | $-0.25 | ||
| Q1 25 | — | $-0.40 | ||
| Q4 24 | $1.16 | $2.56 | ||
| Q3 24 | $4.42 | $-0.46 | ||
| Q2 24 | $-12.48 | $-6.86 | ||
| Q1 24 | $-0.79 | $-1.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.6B | $604.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.7B | $491.3M |
| 总资产 | $6.6B | $2.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ILMNTEM
| Q4 25 | $1.6B | $604.8M | ||
| Q3 25 | — | $655.9M | ||
| Q2 25 | — | $186.3M | ||
| Q1 25 | — | $151.6M | ||
| Q4 24 | $93.0M | $341.0M | ||
| Q3 24 | $70.0M | $388.0M | ||
| Q2 24 | $74.0M | $478.8M | ||
| Q1 24 | — | $79.9M |
股东权益ILMNTEM
| Q4 25 | $2.7B | $491.3M | ||
| Q3 25 | — | $507.8M | ||
| Q2 25 | — | $309.6M | ||
| Q1 25 | — | $326.2M | ||
| Q4 24 | $2.4B | $56.3M | ||
| Q3 24 | $2.1B | $53.7M | ||
| Q2 24 | $1.4B | $98.3M | ||
| Q1 24 | $5.7B | $-1.5B |
总资产ILMNTEM
| Q4 25 | $6.6B | $2.3B | ||
| Q3 25 | — | $2.3B | ||
| Q2 25 | — | $1.6B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | $6.3B | $926.1M | ||
| Q3 24 | $6.0B | $971.7M | ||
| Q2 24 | $6.1B | $864.6M | ||
| Q1 24 | $10.0B | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $321.0M | $-36.8M |
| 自由现金流经营现金流 - 资本支出 | $267.0M | $-41.5M |
| 自由现金流率自由现金流/营收 | 23.0% | -11.3% |
| 资本支出强度资本支出/营收 | — | 1.3% |
| 现金转化率经营现金流/净利润 | 0.96× | — |
| 过去12个月自由现金流最近4个季度 | $935.0M | $-239.1M |
8季度趋势，按日历期对齐
经营现金流ILMNTEM
| Q4 25 | $321.0M | $-36.8M | ||
| Q3 25 | — | $-119.8M | ||
| Q2 25 | — | $44.2M | ||
| Q1 25 | — | $-105.6M | ||
| Q4 24 | $364.0M | — | ||
| Q3 24 | $316.0M | $48.7M | ||
| Q2 24 | $80.0M | $-97.1M | ||
| Q1 24 | $77.0M | $-101.4M |
自由现金流ILMNTEM
| Q4 25 | $267.0M | $-41.5M | ||
| Q3 25 | — | $-126.5M | ||
| Q2 25 | — | $36.6M | ||
| Q1 25 | — | $-107.7M | ||
| Q4 24 | $335.0M | — | ||
| Q3 24 | $284.0M | $48.6M | ||
| Q2 24 | $49.0M | $-105.1M | ||
| Q1 24 | $41.0M | $-107.5M |
自由现金流率ILMNTEM
| Q4 25 | 23.0% | -11.3% | ||
| Q3 25 | — | -37.9% | ||
| Q2 25 | — | 11.6% | ||
| Q1 25 | — | -42.1% | ||
| Q4 24 | 30.3% | — | ||
| Q3 24 | 26.3% | 26.9% | ||
| Q2 24 | 4.4% | -63.3% | ||
| Q1 24 | 3.8% | -73.7% |
资本支出强度ILMNTEM
| Q4 25 | — | 1.3% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 3.0% | 0.0% | ||
| Q2 24 | 2.8% | 4.8% | ||
| Q1 24 | 3.3% | 4.2% |
现金转化率ILMNTEM
| Q4 25 | 0.96× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.96× | — | ||
| Q3 24 | 0.45× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ILMN
| Product revenue | $990.0M | 85% |
| Service and other revenue | $169.0M | 15% |
TEM
暂无分部数据
